Caryn Gordon Mcdowell - Net Worth and Insider Trading
Caryn Gordon Mcdowell Net Worth
The estimated net worth of Caryn Gordon Mcdowell is at least $1 Million dollars as of 2024-04-29. Caryn Gordon Mcdowell is the GC & Chief Compliance Officer of Cytokinetics Inc and owns about 15,000 shares of Cytokinetics Inc (CYTK) stock worth over $980,100. Caryn Gordon Mcdowell is also the Chief Legal & Adm. Officer of Quince Therapeutics Inc and owns about 122,500 shares of Quince Therapeutics Inc (QNCX) stock worth over $129,850. Details can be seen in Caryn Gordon Mcdowell's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Caryn Gordon Mcdowell has not made any transactions after 2022-06-06 and currently still holds the listed stock(s).
Transaction Summary of Caryn Gordon Mcdowell
Caryn Gordon Mcdowell Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Caryn Gordon Mcdowell owns 3 companies in total, including Quince Therapeutics Inc (QNCX) , Revance Therapeutics Inc (RVNC) , and Cytokinetics Inc (CYTK) .
Click here to see the complete history of Caryn Gordon Mcdowell’s form 4 insider trades.
Insider Ownership Summary of Caryn Gordon Mcdowell
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| QNCX | Quince Therapeutics Inc | 2022-06-06 | Chief Legal & Adm. Officer |
| RVNC | Revance Therapeutics Inc | 2018-05-01 | SVP & GC & Secretary |
| CYTK | Cytokinetics Inc | 2018-01-16 | GC & Chief Compliance Officer |
Caryn Gordon Mcdowell Latest Holdings Summary
Caryn Gordon Mcdowell currently owns a total of 2 stocks. Among these stocks, Caryn Gordon Mcdowell owns 15,000 shares of Cytokinetics Inc (CYTK) as of January 16, 2018, with a value of $980,100 and a weighting of 88.3%. Caryn Gordon Mcdowell also owns 122,500 shares of Quince Therapeutics Inc (QNCX) as of June 6, 2022, with a value of $129,850 and a weighting of 11.7%.
Latest Holdings of Caryn Gordon Mcdowell
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CYTK | Cytokinetics Inc | 2018-01-16 | 15,000 | 65.34 | 980,100 |
| QNCX | Quince Therapeutics Inc | 2022-06-06 | 122,500 | 1.06 | 129,850 |
Holding Weightings of Caryn Gordon Mcdowell
Caryn Gordon Mcdowell Form 4 Trading Tracker
According to the SEC Form 4 filings, Caryn Gordon Mcdowell has made a total of 0 transactions in Cytokinetics Inc (CYTK) over the past 5 years. The most-recent trade in Cytokinetics Inc is the sale of 2,709 shares on January 16, 2018, which brought Caryn Gordon Mcdowell around $24,381.
According to the SEC Form 4 filings, Caryn Gordon Mcdowell has made a total of 1 transactions in Quince Therapeutics Inc (QNCX) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Quince Therapeutics Inc is the sale of 10,800 shares on June 6, 2022, which brought Caryn Gordon Mcdowell around $30,888.
Insider Trading History of Caryn Gordon Mcdowell
- 1
Caryn Gordon Mcdowell Trading Performance
Caryn Gordon Mcdowell Ownership Network
Ownership Network List of Caryn Gordon Mcdowell
Ownership Network Relation of Caryn Gordon Mcdowell
Caryn Gordon Mcdowell Owned Company Details
What does Quince Therapeutics Inc do?
Who are the key executives at Quince Therapeutics Inc?
Caryn Gordon Mcdowell is the Chief Legal & Adm. Officer of Quince Therapeutics Inc. Other key executives at Quince Therapeutics Inc include Chief Scientific Officer Guenter Janhofer , President Charles S. Ryan , and director & Chief Executive Officer Dirk Thye .
Quince Therapeutics Inc (QNCX) Insider Trades Summary
Over the past 18 months, Caryn Gordon Mcdowell made no insider transaction in Quince Therapeutics Inc (QNCX). Other recent insider transactions involving Quince Therapeutics Inc (QNCX) include a net purchase of 500,436 shares made by David Lamond , a net purchase of 168,000 shares made by Dirk Thye , and a net purchase of 71,762 shares made by Brendan Hannah .
In summary, during the past 3 months, insiders sold 0 shares of Quince Therapeutics Inc (QNCX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,871 shares of Quince Therapeutics Inc (QNCX) were sold and 748,198 shares were bought by its insiders, resulting in a net purchase of 746,327 shares.
Quince Therapeutics Inc (QNCX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Quince Therapeutics Inc Insider Transactions
Caryn Gordon Mcdowell Mailing Address
Above is the net worth, insider trading, and ownership report for Caryn Gordon Mcdowell. You might contact Caryn Gordon Mcdowell via mailing address: 280 East Grand Avenue, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
